Mackenzie Financial Corp Acquires 4,024 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Mackenzie Financial Corp lifted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 9.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 44,805 shares of the company’s stock after buying an additional 4,024 shares during the quarter. Mackenzie Financial Corp’s holdings in Option Care Health were worth $1,509,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. First Horizon Advisors Inc. bought a new stake in Option Care Health in the 3rd quarter worth $37,000. Headlands Technologies LLC grew its holdings in Option Care Health by 5,796.7% in the 3rd quarter. Headlands Technologies LLC now owns 1,769 shares of the company’s stock worth $57,000 after acquiring an additional 1,739 shares during the last quarter. IFP Advisors Inc grew its holdings in Option Care Health by 20,350.0% in the 3rd quarter. IFP Advisors Inc now owns 2,454 shares of the company’s stock worth $79,000 after acquiring an additional 2,442 shares during the last quarter. Fifth Third Bancorp grew its holdings in Option Care Health by 219.6% in the 3rd quarter. Fifth Third Bancorp now owns 2,723 shares of the company’s stock worth $88,000 after acquiring an additional 1,871 shares during the last quarter. Finally, International Assets Investment Management LLC grew its holdings in Option Care Health by 1,513.7% in the 4th quarter. International Assets Investment Management LLC now owns 3,066 shares of the company’s stock worth $103,000 after acquiring an additional 2,876 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Trading Down 2.2 %

NASDAQ:OPCH opened at $29.93 on Thursday. The company has a 50-day moving average price of $32.13 and a 200-day moving average price of $31.52. Option Care Health, Inc. has a 12 month low of $24.23 and a 12 month high of $35.74. The company has a current ratio of 1.77, a quick ratio of 1.33 and a debt-to-equity ratio of 0.74. The stock has a market cap of $5.20 billion, a price-to-earnings ratio of 20.36, a P/E/G ratio of 1.73 and a beta of 1.22.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.22 by $0.04. Option Care Health had a net margin of 6.21% and a return on equity of 18.78%. The firm had revenue of $1.15 billion during the quarter, compared to analysts’ expectations of $1.10 billion. During the same period last year, the company posted $0.21 EPS. The company’s quarterly revenue was up 12.8% compared to the same quarter last year. Equities analysts predict that Option Care Health, Inc. will post 1.13 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Barrington Research reissued an “outperform” rating and issued a $38.00 price target on shares of Option Care Health in a report on Wednesday. Jefferies Financial Group raised their target price on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday, March 4th.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the stock in a transaction that occurred on Monday, February 26th. The stock was bought at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the transaction, the director now directly owns 269,528 shares in the company, valued at approximately $8,503,608.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.